全球关节痛注射市场

到 2030 年，全球关节疼痛注射市场将达到 55 亿美元

全球关节疼痛注射剂市场规模预计在2024年达到38亿美元，预计在分析期内（2024-2030年）的复合年增长率为6.7%，到2030年将达到55亿美元。透明质酸注射剂是本报告分析的细分市场之一，预计其复合年增长率为6.3%，到分析期结束时规模将达到34亿美元。皮质类固醇注射市场规模预计在分析期间的复合年增长率为7.6%。

美国市场规模估计为 10 亿美元，中国市场预计复合年增长率为 10.4%

美国关节痛注射市场规模预计2024年达到10亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到11亿美元，在2024-2030年的分析期间内，复合年增长率为10.4%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为3.3%和6.4%。在欧洲，预计德国市场的复合年增长率为4.4%。

全球关节痛注射市场－主要趋势与驱动因素摘要

由于关节炎、骨关节炎和其他肌肉骨骼疾病的盛行率不断上升，关节疼痛注射市场正在经历显着增长。全球人口老化和与生活方式相关的关节问题的日益增多，推动了对有效、微创疼痛管理解决方案的需求激增。关节疼痛注射，包括皮质类固醇、透明质酸、富血小板血浆 (PRP) 和干细胞治疗方法，被广泛用于缓解疼痛、改善活动能力并延缓关节关节重建等外科手术。生技药品、精准医疗和再生疗法的进步，使关节疼痛管理更加有效和个人化，进一步改变了市场格局。

哪些新兴趋势正在影响关节痛注射市场？

关节疼痛注射市场最显着的趋势之一是人们偏好，尤其是富血小板血浆 (PRP) 和干细胞注射。 PRP 疗法源自于患者自身血液，正越来越多地被用于促进组织癒合，并减轻骨关节炎和运动伤害中的发炎。同样，干细胞注射，尤其是间质干细胞(MSC)，因其再生软骨和减缓疾病进展的能力而受到研究。在正在进行的临床试验和研究进展的支持下，随着患者寻求皮质类固醇和透明质酸的替代品，再生疗法的应用预计将会扩大。

另一个重要趋势是个人化医疗在关节疼痛管理中的兴起。基因检测、生物标记分析和影像技术的进步使医生能够根据患者的个别情况客製化注射治疗方案。个人化治疗方案透过根据关节退化的严重程度、发炎反应和患者的整体健康状况来确定最佳注射类型，从而提高疗效、减少副作用并优化治疗结果。这种向精准医疗的转变正在提高患者满意度，并推动对先进诊断工具以及关节疼痛注射剂的需求。

微创技术和影像引导注射程序也越来越受欢迎。利用超音波和萤光透视技术精确定位针头，提高了关节注射的准确性和有效性，减轻了疼痛，并最大限度地减少了併发症。影像导引註射在髋关节和脊椎等深层关节尤其有效，而传统的盲注已被证明对这些部位无效。随着技术的进步，越来越多的诊所和医院开始采用引导注射，从而改善了患者的治疗效果，并推动了市场需求。

技术进步如何推动市场？

技术创新正在透过提高疗效、安全性和持久性，彻底改变关节疼痛注射剂市场。其中最重要的进展之一是新一代关节内粘稠补充疗法的开发。传统的玻尿酸注射剂透过润滑关节提供暂时缓解，而采用关节内粘稠补充疗法透明质酸的新配方则能提供更持久的疗效并增强黏弹性。这些进展使得黏弹性补充疗法对希望延后关节重建手术的轻度至中度骨关节炎患者更具吸引力。

另一个突破是利用控制释放技术开发长效皮质类固醇注射。传统的皮质类固醇注射可以快速缓解疼痛，但作用时间较短。采用微球递送系统的新配方旨在提供长达数月的持续抗发炎效果。此类创新对于需要长期缓解疼痛且无需频繁注射的慢性关节痛患者尤其有益。

生物製药和细胞治疗方法在关节疼痛管理方面也取得了长足进展。外泌体疗法是一种新型再生疗法，因其在细胞层面修復软骨损伤和调节发炎的潜力而备受关注。与富血小板血浆（PRP）和干细胞不同，外泌体注射剂不含细胞，这意味着它们只含有源自干细胞的有益讯号分子，从而降低了免疫排斥和副作用的风险。随着再生医学研究的进展，外泌体疗法和其他新型生技药品预计将成为关节疼痛注射剂市场的主要企业。

是什么推动了关节痛注射市场的成长？

关节疼痛注射市场的成长受到多种因素的推动，包括骨关节炎和慢性关节疾病的盛行率不断上升、对非手术疼痛管理解决方案的需求不断增长，以及生技药品和再生医学的进步。全球人口老化是市场扩张的主要推动因素，因为老年人更容易患关节退化和关节炎。根据世界卫生组织 (WHO) 的数据，骨关节炎是全球主要的残疾原因之一，这加剧了对有效且持久的关节疼痛治疗的需求。

运动医学和整形外科復健领域日益壮大也是市场发展的关键驱动力。运动员和体力活动者经常会遭遇关节损伤，需要微创治疗才能更快康復。 PRP注射和其他生物疗法在运动医学中的应用日益广泛，旨在加速癒合并减少恢復期，这促进了关节疼痛注射的需求增长。此外，提供注射式疼痛管理解决方案的门诊病人和流动护理中心的增多，也改善了患者的就诊管道，并提升了市场渗透率。

另一个关键的成长要素是关节疼痛联合治疗的接受度日益提高。越来越多的医生将不同类型的注射剂组合使用以增强治疗效果，例如PRP和透明质酸，或皮质类固醇和干细胞疗法。这种多模态疗法不仅可以立即缓解疼痛，还能透过同时解决发炎和组织再生问题来支持长期关节健康。随着联合治疗的普及，市场先驱们正在投资临床研究，以开发能够最大程度提高疗效和患者满意度的最佳治疗通讯协定。

随着对有效、微创关节疼痛解决方案的需求持续成长，关节疼痛注射市场预计将大幅成长。再生医学、生物疗法和个人化治疗方法的进步将在塑造该行业的未来方面发挥关键作用，为患者提供比手术更好的替代方案和长期缓解疼痛的方法。

部分

注射类型（透明质酸注射、皮质类固醇注射、富血小板血浆注射）、关节类型（膝关节、肩/肘关节、踝/髋关节、其他关节类型）、最终用户（医院、诊所、其他最终用户）

受访公司范例

• AbbVie Inc.
• Anika Therapeutics, Inc.
• Arthrex, Inc.
• Bioventus LLC
• Chugai Pharmaceutical Co., Ltd.
• Dr. Reddy's Laboratories Ltd.
• Eli Lilly and Company
• Emcyte Corporation
• Ferring Pharmaceuticals
• Flexion Therapeutics, Inc.
• Lifecore Biomedical
• Ono Pharmaceutical Co., Ltd.
• OrthogenRx, Inc.
• Pacira BioSciences, Inc.
• Pfizer Inc.
• Sanofi
• SEIKAGAKU CORPORATION
• Stryker Corporation
• Teva Pharmaceutical Industries Ltd.
• Zimmer Biomet Holdings, Inc.

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 比赛

Global Joint Pain Injections Market to Reach US$5.5 Billion by 2030

The global market for Joint Pain Injections estimated at US$3.8 Billion in the year 2024, is expected to reach US$5.5 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Hyaluronic acid injections, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$3.4 Billion by the end of the analysis period. Growth in the Corticosteroid injections segment is estimated at 7.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.0 Billion While China is Forecast to Grow at 10.4% CAGR

The Joint Pain Injections market in the U.S. is estimated at US$1.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 10.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Joint Pain Injections Market - Key Trends & Drivers Summarized

The joint pain injections market is witnessing significant growth due to the rising prevalence of arthritis, osteoarthritis, and other musculoskeletal disorders. With an aging global population and increasing lifestyle-related joint issues, demand for effective, minimally invasive pain management solutions has surged. Joint pain injections, including corticosteroids, hyaluronic acid, platelet-rich plasma (PRP), and stem cell-based therapies, are widely used to alleviate pain, improve mobility, and delay surgical interventions such as joint replacement. Advances in biologics, precision medicine, and regenerative therapies are further transforming the market, making joint pain management more effective and personalized.

What Are the Emerging Trends Shaping the Joint Pain Injections Market?

One of the most notable trends in the joint pain injections market is the growing preference for regenerative medicine, particularly platelet-rich plasma (PRP) and stem cell-based injections. PRP therapy, derived from the patient’s own blood, is increasingly being used to promote tissue healing and reduce inflammation in osteoarthritis and sports injuries. Similarly, stem cell injections, particularly mesenchymal stem cells (MSCs), are being researched for their ability to regenerate cartilage and delay disease progression. As patients seek alternatives to corticosteroids and hyaluronic acid, the adoption of regenerative therapies is expected to grow, supported by ongoing clinical trials and research advancements.

Another significant trend is the rise of personalized medicine in joint pain management. Advances in genetic testing, biomarker analysis, and imaging technologies are enabling physicians to tailor injection treatments to individual patient profiles. Personalized treatment plans improve efficacy, reduce side effects, and optimize outcomes by identifying the most suitable injection type based on the severity of joint degeneration, inflammatory response, and overall patient health. This shift towards precision medicine is enhancing patient satisfaction and driving demand for advanced diagnostic tools alongside joint pain injections.

Minimally invasive techniques and image-guided injection procedures are also gaining traction. The use of ultrasound and fluoroscopy for precise needle placement has improved the accuracy and effectiveness of joint injections, reducing pain and minimizing complications. Image-guided injections are particularly beneficial for deep-seated joints such as the hip and spine, where traditional blind injections may be less effective. As technology advances, more clinics and hospitals are adopting guided injection procedures, leading to improved patient outcomes and higher market demand.

How Are Technological Advancements Driving the Market?

Technological innovations are revolutionizing the joint pain injections market by enhancing the effectiveness, safety, and longevity of treatments. One of the most significant advancements is the development of next-generation viscosupplementation therapies. Traditional hyaluronic acid injections provide temporary relief by lubricating the joint, but newer formulations with cross-linked hyaluronic acid offer longer-lasting effects and improved viscoelastic properties. These advancements have made viscosupplementation more appealing to patients with mild to moderate osteoarthritis who want to delay joint replacement surgery.

Another breakthrough is the development of long-acting corticosteroid injections with controlled-release technology. Traditional corticosteroid injections provide rapid pain relief but have a short duration of effect. Newer formulations with microsphere-based delivery systems are being designed to provide sustained anti-inflammatory benefits over several months. These innovations are particularly beneficial for patients with chronic joint pain who require prolonged relief without frequent injections.

Biologics and cell-based therapies are also making significant strides in joint pain management. Exosome therapy, a novel regenerative approach, is gaining attention for its potential to repair cartilage damage and modulate inflammation at a cellular level. Unlike PRP and stem cells, exosome-based injections are acellular, meaning they contain only the beneficial signaling molecules derived from stem cells, reducing the risk of immune rejection or adverse reactions. As research in regenerative medicine advances, exosome therapy and other novel biologics are expected to become key players in the joint pain injections market.

What Is Driving the Growth of the Joint Pain Injections Market?

The growth in the joint pain injections market is driven by several factors, including the increasing prevalence of osteoarthritis and chronic joint disorders, the rising demand for non-surgical pain management solutions, and advancements in biologics and regenerative medicine. The aging global population is a major contributor to market expansion, as older individuals are more susceptible to joint degeneration and arthritis. According to the World Health Organization (WHO), osteoarthritis is among the leading causes of disability worldwide, fueling the need for effective, long-lasting joint pain treatments.

The expanding role of sports medicine and orthopedic rehabilitation is also a significant market driver. Athletes and physically active individuals frequently experience joint injuries that require minimally invasive treatments for faster recovery. PRP injections and other biologic therapies are increasingly being used in sports medicine to accelerate healing and reduce downtime, contributing to the growing demand for joint pain injections. Additionally, the increasing number of outpatient and ambulatory care centers offering injection-based pain management solutions is improving patient access and market penetration.

Another critical growth driver is the growing acceptance of combination therapies for joint pain. Physicians are increasingly combining different injection types-such as PRP with hyaluronic acid or corticosteroids with stem cell therapy-to enhance treatment outcomes. This multi-modal approach not only provides immediate pain relief but also supports long-term joint health by addressing both inflammation and tissue regeneration. As combination therapies gain traction, market players are investing in clinical research to develop optimized treatment protocols that maximize efficacy and patient satisfaction.

As the demand for effective, minimally invasive joint pain solutions continues to rise, the market for joint pain injections is expected to grow significantly. Advances in regenerative medicine, biologic therapies, and personalized treatment approaches will play a key role in shaping the future of the industry, offering patients better alternatives to surgery and long-term pain relief.

SCOPE OF STUDY:

The report analyzes the Joint Pain Injections market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Injection Type (Hyaluronic acid injections, Corticosteroid injections, Platelet rich plasma injections); Joint Type (Knee, Shoulder & elbow, Ankle & hip, Other joint types); End-Use (Hospitals, Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• AbbVie Inc.
• Anika Therapeutics, Inc.
• Arthrex, Inc.
• Bioventus LLC
• Chugai Pharmaceutical Co., Ltd.
• Dr. Reddy's Laboratories Ltd.
• Eli Lilly and Company
• Emcyte Corporation
• Ferring Pharmaceuticals
• Flexion Therapeutics, Inc.
• Lifecore Biomedical
• Ono Pharmaceutical Co., Ltd.
• OrthogenRx, Inc.
• Pacira BioSciences, Inc.
• Pfizer Inc.
• Sanofi
• SEIKAGAKU CORPORATION
• Stryker Corporation
• Teva Pharmaceutical Industries Ltd.
• Zimmer Biomet Holdings, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Joint Pain Injections - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Osteoarthritis and Degenerative Joint Conditions Propels Demand for Pain Injections
  • Growing Preference for Minimally Invasive Pain Management Strengthens Business Case for Injectable Therapies
  • Increasing Aging Population Globally Expands Addressable Market for Joint Pain Injections
  • Rapid Adoption of Hyaluronic Acid Injections Spurs Growth in the Knee Osteoarthritis Treatment Segment
  • Expansion of Sports Medicine and Injury Recovery Markets Drives Demand for Corticosteroid Injections
  • Advancements in Regenerative Medicine Accelerate Interest in Platelet-Rich Plasma and Stem Cell Injections
  • Rising Healthcare Expenditure and Insurance Coverage Boost Access to Joint Pain Injection Therapies
  • Physician Preference for In-Office Injectable Solutions Enhances Procedural Volume and Product Demand
  • Increasing Awareness of Early Intervention in Joint Disorders Drives Use of Injections at Earlier Disease Stages
  • Innovation in Long-Acting Formulations Strengthens Value Proposition for Chronic Pain Sufferers
  • Development of Targeted Biologic Injections Expands Therapeutic Options in Inflammatory Joint Diseases
  • Growing Demand for Personalized Pain Management Throws the Spotlight on Customized Injection Protocols
  • Shift Towards Outpatient and Ambulatory Care Settings Spurs Demand for Fast-Acting Injectable Solutions
  • Rise in Orthopedic Clinics and Specialty Pain Management Centers Enhances Distribution and Administration
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Joint Pain Injections Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Joint Pain Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Joint Pain Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Joint Pain Injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Hyaluronic acid injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Hyaluronic acid injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Hyaluronic acid injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Corticosteroid injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Corticosteroid injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Corticosteroid injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Platelet rich plasma injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Platelet rich plasma injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Platelet rich plasma injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Knee by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Knee by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Knee by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Shoulder & elbow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Shoulder & elbow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Shoulder & elbow by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Ankle & hip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Ankle & hip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Ankle & hip by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Other joint types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Other joint types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Other joint types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• JAPAN
  • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• CHINA
  • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• EUROPE
  • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Joint Pain Injections by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Joint Pain Injections by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Joint Pain Injections by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• FRANCE
  • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• GERMANY
  • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 110: UK Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Joint Pain Injections by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Joint Pain Injections by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Joint Pain Injections by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• INDIA
  • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 167: India Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Joint Pain Injections by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Joint Pain Injections by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Joint Pain Injections by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Joint Pain Injections by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Joint Pain Injections by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Joint Pain Injections by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030
• AFRICA
  • Joint Pain Injections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Joint Pain Injections by Injection Type - Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Joint Pain Injections by Injection Type - Percentage Breakdown of Value Sales for Hyaluronic acid injections, Corticosteroid injections and Platelet rich plasma injections for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Joint Pain Injections by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Joint Pain Injections by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Joint Pain Injections by Joint Type - Knee, Shoulder & elbow, Ankle & hip and Other joint types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Joint Pain Injections by Joint Type - Percentage Breakdown of Value Sales for Knee, Shoulder & elbow, Ankle & hip and Other joint types for the Years 2015, 2025 & 2030

IV. COMPETITION